 |
Twice-Weekly Briefing
Tuesday, November 17, 2026
Issue 261117-81
|
|
|
The MOC Brief
Health policy, priced and translated for self-funded plan sponsors
|
|
In This Edition
Five developments, and what each one costs you.
| 1. | CVS Health modeled the net monthly drug price at which it says GLP-1 coverage stops adding cost: about $350. | | 2. | ONC and CMS opened electronic prior authorization testing to payers, providers and vendors, with expressions of interest due November 20. | | 3. | Florida penalized pharmacy benefit managers over contract terms in four areas. | | 4. | A median 1.2 percent of members, each above $100,000 in annual claims, were driving 39.2 percent of medical plan costs in a survey of health systems. | | 5. | The state's leading private health plan posted a $43.5 million operating and other loss for the quarter. |
|
|
| 1 · PHARMACY ECONOMICS · November 15, 2026 |
| CVS Health Modeled the Net Price at Which It Says GLP-1 Coverage Stops Adding Cost |
| CVS Health released an analysis of its own Aetna claims on November 15, 2026, finding better outcomes and lower medical spending but concluding that current prices limit the full economic value. Its internal modeling puts the balance point at a net price of approximately $350 per month over three years, a figure CVS states across the study population rather than per patient, and CVS says the break-even point varies with a patient's underlying clinical risk, how long they stay on treatment, and how consistently they take the drug. The analysis matched members starting a GLP-1 against similar non-users on factors including age, existing health conditions, and prior health care use and prior medical and pharmacy spending, across index years 2023 through 2025 with up to three years of follow-up. It compared everyone who started a GLP-1 against the subset whose prescriptions covered at least 80 percent of days during follow-up, which CVS calls a standard measure of medication adherence. CVS puts the number of US adults medically eligible for semaglutide across indications at more than 137 million. The study population is stated in CVS's own words as commercial fully insured Aetna members, no outside party checked the work, and CVS published no funding or conflict disclosure. |
|
MOC Perspective
You now have a public number from the company whose own book produced it. That figure is the one to put in front of your PBM, and the question to ask is what your own contract actually nets, before your 2027 GLP-1 policy closes. The arithmetic that matters here is the one CVS ran, medical spend and pharmacy spend read as a single net result, and most plans still see those two in separate reports from separate vendors. Ask for it on your own claims rather than borrowing a fully insured book's answer.
What to do now
| ▪ | Ask your PBM in writing this week for your plan's net GLP-1 cost per member per month, and set it against the $350 figure. | | ▪ | Request one report combining medical and pharmacy spend for your GLP-1 users over the last 24 months, instead of two reports from two vendors. | | ▪ | Write your 2027 GLP-1 coverage and adherence rules before January 1, using the three conditions CVS names: treat the patients most likely to benefit, support people staying on therapy, and get the price down. |
|
|
| Source: CVS Health, company news release, November 15, 2026 |
|
| 2 · PRIOR AUTHORIZATION STANDARDS · November 12, 2026 |
| ONC and CMS Opened Electronic Prior Authorization Testing Ahead of 2027 Requirements |
| ONC and CMS announced a joint industry testing initiative for electronic prior authorization on November 12, 2026, and asked organizations interested in participating to learn more and express their interest by November 20. The announcement frames the work as a chance for trading partners to test prior authorization workflows together ahead of 2027 requirements, and it cites no rule and names no compliance date. Testing runs in sprints of 10 to 12 weeks, in which participants put their own workflows through connected systems using the HL7 FHIR Da Vinci implementation guides for Coverage Requirements Discovery, Documentation Templates and Rules, and Prior Authorization Support. ONC and CMS engaged both Drummond Group and the MITRE-led Health Federally Funded Research and Development Center to support recruitment, readiness discussions, participant matching and testing coordination, and Drummond Group will operate the testing environment, named FHIRplace. The invitation names payers, providers, hospitals, electronic health record developers, intermediaries and other industry partners, and says nothing about line of business either way. ONC and CMS say first-round space is limited, that participation in testing is voluntary, and that the testing is not certification under the ONC Health IT Certification Program or a determination of compliance with CMS requirements. |
|
MOC Perspective
The announcement does not say which plan types are in scope, and it does not define what it means by intermediaries. Your administrator may or may not sit inside one of the invited categories, which is worth one email to find out. If it is not testing, your plan risks staying on fax and phone while the providers you contract with build interfaces for the payers that are. Interest is due Friday, and since participation is voluntary, nobody will chase your administrator about it either.
What to do now
| ▪ | Email your TPA or ASO carrier before November 20 and ask whether it is expressing interest in the ONC and CMS testing sprints. | | ▪ | Ask for your administrator's electronic prior authorization roadmap in writing within 30 days if the answer comes back no. | | ▪ | Put the 10 to 12 week sprint length on your 2027 vendor review calendar, so you can ask your administrator what it learned. |
|
|
| Source: Office of the National Coordinator for Health IT, news release, November 12, 2026 |
|
| 3 · PBM ENFORCEMENT · November 9, 2026 |
| Florida's Insurance Commissioner Penalized Pharmacy Benefit Managers More Than $12.66 Million |
| Florida Insurance Commissioner Mike Yaworsky announced penalties of over $12.66 million against pharmacy benefit managers on November 9, 2026, following market conduct examinations. The office says it found violations in pharmacy benefit plans or program contracts and in participating pharmacy contracts, across four areas: fair pricing models, network adequacy and fair access, pharmacy remittances, and the prohibition of unilateral changes to pharmacy contracts. Yaworsky said the state must demand transparency and accountability for all PBMs in Florida "to ensure companies cannot hide revenue, retain rebates instead of passing savings to consumers, or raise costs for patients who may rely heavily on critical prescriptions." The office also said several of these PBMs are actively pushing back against its findings or penalties and pursuing litigation, that the completion of certain examinations is delayed because certain PBMs are not cooperating with the statutory examinations, and that in certain instances examiner invoices have not been paid by the examined PBM since January 2025. Florida has been able to examine each PBM every two years since the Prescription Drug Reform Act was signed in May 2023. The release's own text names no individual PBM and gives no count, presenting the breakdown as a graphic instead. |
|
MOC Perspective
Florida examined the PBM's contracts on both sides, the ones it signs with plans and programs and the ones it signs with participating pharmacies, and the fourth area names pharmacy contracts explicitly. So the prohibition on unilateral changes protects the pharmacy, not you. The release does not say whether these duties reach a self-funded ERISA plan's contract at all, which makes this a map of where the problems sit and a template worth borrowing, rather than relief you can claim.
What to do now
| ▪ | Pull your PBM agreement within 7 days and find the clause that lets the PBM amend terms without your consent, since Florida's prohibition covers pharmacy contracts and not yours. | | ▪ | Ask your PBM for its pricing definitions in writing, covering all four areas Florida examined, at least 30 days before your next renewal. | | ▪ | Add a 30 day written notice and consent requirement for any amendment to your next PBM contract redline. |
|
|
| Source: Florida Office of Insurance Regulation, news release, November 9, 2026 |
|
| 4 · HIGH-COST CLAIMANTS · November 12, 2026 |
| Aon Found a Median 1.2 Percent of Members Driving 39.2 Percent of Medical Plan Costs |
| Aon released findings from its 2026 Benefits Survey of Hospitals on November 12, 2026, reporting that across participating health systems the median share of members with annual medical claims over $100,000 was just 1.2 percent, yet those members account for 39.2 percent of medical plan costs. Per employee per year spend rose 8.8 percent among systems participating year over year, and Aon gives no dollar figure behind that percentage, so you cannot convert it to your own number. Ninety-two percent of participating systems named cost a top concern, thirty-eight percent are using predictive analytics to proactively identify and engage potential high-cost claimants, and sixty-four percent use carrier clinical and case management programs against twenty-one percent using healthcare navigation or advocacy vendors. The universe is over 1,800 hospitals across 170 US healthcare systems representing over 4.2 million covered employees, and Aon does not say when it collected the data. Aon's own disclaimer says survey results reflect participating health systems and may not be representative of all health systems or employers. |
|
MOC Perspective
A concentration like that is the arithmetic most self-funded plans live under in some form, and most sponsors have never run it on their own claims. Ask for it before your stop-loss renewal, because a specific deductible set without knowing your own concentration is a deductible set on somebody else's. Read the benchmark carefully, though: these are health systems as employers, and eighty-three percent of them offer employees lower costs for care through their own facilities or providers, which is not a move available to you.
What to do now
| ▪ | Ask your TPA for a claimant tier report showing what share of your members crossed $100,000 in the last 12 months and what share of paid medical they account for. | | ▪ | Set that result against Aon's health-system figures before you sign your 2027 stop-loss specific deductible. | | ▪ | Ask your carrier or TPA within 30 days whether you get prospective high-cost claimant identification or only retrospective reporting, and get the answer in writing. |
|
|
| Source: Aon, 2026 Benefits Survey of Hospitals news release, November 12, 2026 |
|
| 5 · CARRIER FINANCES · November 13, 2026 |
| Massachusetts' Leading Private Health Plan Posted a $43.5 Million Operating and Other Loss |
| Blue Cross Blue Shield of Massachusetts reported third quarter 2026 results on November 13, 2026, showing an operating and other loss of $43.5 million, a negative 1.6 percent operating margin, on quarterly revenue of $2.7 billion. After-tax net income for the quarter was $2.2 million, a 0.1 percent net margin, held up by $45.7 million of investment income. Year to date the figures read differently: operating and other income of $9.5 million, a 0.1 percent operating margin, and after-tax net income of $145.1 million on revenue of $8.1 billion, a 1.8 percent net margin, with $135.6 million of that income coming from investments. The carrier attributes the quarter primarily to increased spending on prescription medications for its members, particularly expensive specialty drugs, together with an ongoing rise in the complexity and intensity of medical care, and says the year to date results also reflect a premium deficiency reserve. Chief financial officer Ruby Kam said steep increases in specialty drug prices and complex care demand continue to drive up expenses, and that internal spending discipline and positive investment returns help buffer these pressures today but are not a permanent fix. Kam also said national spending is rising at rates not seen since the early 1980s and that Massachusetts cost growth has exceeded state benchmarks for four years running, and the release attributes neither of those statements to any outside body or statistic. |
|
MOC Perspective
A plan that covers 3 million members and names specialty drugs as its own cost driver is a plan that will price your 2027 administrative fees and trend assumptions off that experience. Kam closed by saying that to make coverage truly affordable for "our members and employer customers," the underlying cost drivers have to be addressed, and your plan is one of those employer customers. The release breaks out no self-funded or ASO book anywhere, though, so it cannot tell you what your own segment did. If you have Massachusetts lives, ask for the specialty trend assumption behind your renewal and whether it came from your claims or the carrier's book.
What to do now
| ▪ | Ask your carrier to show the specialty drug trend assumption inside your 2027 renewal, stated as a percentage, before your renewal meeting. | | ▪ | Request your plan's own specialty drug spend for the last 12 months, and check it against the trend you are being charged. | | ▪ | Get your 2027 administrative fee and trend quotes in writing before December 31, while the renewal is still open. |
|
|
| Source: Blue Cross Blue Shield of Massachusetts, news release, November 13, 2026 |
|
|
The Bottom Line
Four of these five hand you a question before they hand you a date: what your plan actually nets on a GLP-1, what share of your spend sits with a handful of claimants, what your PBM can change without asking you, and what trend assumption is buried in your renewal. Only the prior authorization story runs on somebody else's clock, and that one closes Friday. None of these five documents is written for a self-funded plan, so the line from each of them to your plan is one you have to draw yourself. All five are published and free to read. The arithmetic is the part nobody runs for you.
|
|
|
Jude Odu
Founder and Principal, Model Optimal Care
Author of Model Optimal Care: End U.S. Healthcare Waste, One Health Plan at a Time
|
|
|
|